Loading...
XSHG600055
Market cap1.37bUSD
Jan 15, Last price  
14.33CNY
1D
-1.10%
1Q
8.56%
Jan 2017
10.72%
Name

Beijing Wandong Medical Technology Co Ltd

Chart & Performance

D1W1MN
XSHG:600055 chart
P/E
53.44
P/S
8.15
EPS
0.27
Div Yield, %
0.84%
Shrs. gr., 5y
4.98%
Rev. gr., 5y
5.32%
Revenues
1.24b
+10.30%
479,938,932494,946,524514,811,927532,265,890603,596,283683,441,239602,754,359588,805,176690,346,218764,680,965739,874,867818,218,095813,400,702883,958,514954,529,650982,372,0191,131,904,7921,156,174,6861,121,203,5481,236,669,630
Net income
189m
+7.51%
32,183,65317,572,70229,541,24428,001,32228,366,29668,599,53241,945,18639,887,90332,257,02543,623,19825,692,56740,298,12471,543,783109,117,143153,333,141168,884,369220,667,405183,193,054175,369,143188,537,925
CFO
208m
+12.30%
063,579,96248,545,425090,743,456144,175,3910065,747,96521,494,23634,324,6010102,736,486075,530,39594,784,204520,025,42489,723,684185,408,318208,218,000
Dividend
May 17, 20240.13 CNY/sh
Earnings
Apr 18, 2025

Profile

Beijing Wandong Medical Technology Co., Ltd. engages in the research and development, manufacturing, and sale of medical diagnostic service. It offers MRI solutions; radiological imaging solutions, including CT system, CGO series, DR system, DRF system, digital mammography, and mobile X-ray equipment. The company was formerly known as China Resources Wandong Medical Equipment Co., Ltd. The company was founded in 1955 and is based in Beijing, China.
URL
https://www.wandong.com.cn/
IPO date
May 19, 1997
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
1,236,670
10.30%
1,121,204
-3.02%
Cost of revenue
991,433
961,783
Unusual Expense (Income)
NOPBT
245,237
159,421
NOPBT Margin
19.83%
14.22%
Operating Taxes
22,522
20,399
Tax Rate
9.18%
12.80%
NOPAT
222,714
139,022
Net income
188,538
7.51%
175,369
-4.27%
Dividends
(84,367)
(70,306)
Dividend yield
0.71%
0.55%
Proceeds from repurchase of equity
BB yield
Debt
Debt current
6,260
Long-term debt
22,374
31,329
Deferred revenue
26,637
Other long-term liabilities
38,801
17,207
Net debt
(3,779,646)
(3,531,706)
Cash flow
Cash from operating activities
208,218
185,408
CAPEX
(17,126)
Cash from investing activities
59,970
150,198
Cash from financing activities
(86,785)
2,024,965
FCF
220,334
103,941
Balance
Cash
3,440,843
3,341,791
Long term investments
361,177
227,503
Excess cash
3,740,186
3,513,234
Stockholders' equity
2,061,105
1,951,098
Invested Capital
2,809,507
2,791,271
ROIC
7.95%
6.67%
ROCE
5.03%
3.36%
EV
Common stock shares outstanding
698,289
649,515
Price
17.08
-12.59%
19.54
-17.93%
Market cap
11,926,770
-6.03%
12,691,530
-0.53%
EV
8,256,275
9,265,039
EBITDA
285,596
194,124
EV/EBITDA
28.91
47.73
Interest
1,698
1,466
Interest/NOPBT
0.69%
0.92%